148 related articles for article (PubMed ID: 28961664)
21. Academic psychiatry and the pharmaceutical industry.
Ban TA
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):429-41. PubMed ID: 16442686
[TBL] [Abstract][Full Text] [Related]
22. Cognition Disturbances in Psychiatry: Neurobiology and Treatment (In memory of David de Wied), May 15-16, 2009, Catalina, Italy.
Eur J Pharmacol; 2010 Jan; 626(1):1-112. PubMed ID: 19846042
[No Abstract] [Full Text] [Related]
23. From genes to therapeutic targets for psychiatric disorders - what to expect?
Muglia P
Curr Opin Pharmacol; 2011 Oct; 11(5):563-71. PubMed ID: 21893430
[TBL] [Abstract][Full Text] [Related]
24. History of Norwegian psychiatry.
Kringlen E
Nord J Psychiatry; 2012 Mar; 66 Suppl 1():31-41. PubMed ID: 22324732
[TBL] [Abstract][Full Text] [Related]
25. The NIMH 'Fast-Fail Trials' (FAST) Initiative: Rationale, Promise, and Progress.
Grabb MC; Hillefors M; Potter WZ
Pharmaceut Med; 2020 Aug; 34(4):233-245. PubMed ID: 32705569
[TBL] [Abstract][Full Text] [Related]
26. Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank.
Dean B; Moller HJ; Svensson TH; Geyer MA; Rujescu D; Scarr E; Millan MJ
Int J Neuropsychopharmacol; 2014 Jan; 17(1):137-48. PubMed ID: 24063634
[TBL] [Abstract][Full Text] [Related]
27. Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders.
Millan MJ; Goodwin GM; Meyer-Lindenberg A; Ove Ögren S
Eur Neuropsychopharmacol; 2015 May; 25(5):599-656. PubMed ID: 25836356
[TBL] [Abstract][Full Text] [Related]
28. [History of Clinical Psychiatry of Sapienza University of Rome in Policlinico Umberto I].
Coccanari de' Fornari MA; Iannitelli A; Biondi M
Riv Psichiatr; 2017; 52(1):1-8. PubMed ID: 28287191
[TBL] [Abstract][Full Text] [Related]
29. A Brief History of Lithium Treatment in Psychiatry.
Ruffalo ML
Prim Care Companion CNS Disord; 2017 Oct; 19(5):. PubMed ID: 29045768
[TBL] [Abstract][Full Text] [Related]
30. Epilepsy, psychiatry, and neurology.
Reynolds EH; Trimble MR
Epilepsia; 2009 Mar; 50 Suppl 3():50-5. PubMed ID: 19298432
[TBL] [Abstract][Full Text] [Related]
31. Advances in Drug Discovery and Development in Geriatric Psychiatry.
C Conley A; A Newhouse P
Curr Psychiatry Rep; 2018 Mar; 20(2):10. PubMed ID: 29504046
[TBL] [Abstract][Full Text] [Related]
32. Towards a clinical methodology for neuropsychopharmacological research.
Ban TA
Neuropsychopharmacol Hung; 2007 Jun; 9(2):81-90. PubMed ID: 17970531
[TBL] [Abstract][Full Text] [Related]
33. What Should Clinicians Know About Palliative Psychopharmacology?
Aftab A
AMA J Ethics; 2023 Sep; 25(9):E710-717. PubMed ID: 37695874
[TBL] [Abstract][Full Text] [Related]
34. Industry withdrawal from psychiatric medication development.
Klein DF; Glick ID
Braz J Psychiatry; 2014 Sep; 36(3):259-61. PubMed ID: 24918522
[TBL] [Abstract][Full Text] [Related]
35. Finnish psychiatry--past and present.
Pylkkänen K
Nord J Psychiatry; 2012 Mar; 66 Suppl 1():14-24. PubMed ID: 21770822
[TBL] [Abstract][Full Text] [Related]
36. Opportunities and challenges in the discovery of new central nervous system drugs.
Krause JE; Chenard BL
Ann N Y Acad Sci; 2008 Nov; 1144():243-50. PubMed ID: 19076381
[TBL] [Abstract][Full Text] [Related]
37. How induced pluripotent stem cells are informing drug discovery in psychiatry.
Sun Y; Dolmetsch RE
Swiss Med Wkly; 2016; 146():w14241. PubMed ID: 26752334
[TBL] [Abstract][Full Text] [Related]
38. Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology.
Tricklebank MD; Robbins TW; Simmons C; Wong EHF
Psychopharmacology (Berl); 2021 Jun; 238(6):1417-1436. PubMed ID: 33694032
[TBL] [Abstract][Full Text] [Related]
39. CNS Drug Development, Lessons Learned, Part 5: How Preclinical and Human Safety Studies Inform the Approval and Subsequent Use of a New Drug-Suvorexant as an Example.
Preskorn SH
J Psychiatr Pract; 2018 Mar; 24(2):104-110. PubMed ID: 29509180
[TBL] [Abstract][Full Text] [Related]
40. Psychotherapy as an epigenetic 'drug': psychiatric therapeutics target symptoms linked to malfunctioning brain circuits with psychotherapy as well as with drugs.
Stahl SM
J Clin Pharm Ther; 2012 Jun; 37(3):249-53. PubMed ID: 22594604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
